EUVIMEDEUVIMED entdecken
Crossref

Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis

Shengting Dong, Huapan Fang iD, Junjie Zhu, Zhiqiang Wu, Yi Liu, Jiafei Zhu, Benting Ma, Qian Chen iD, Yang Yang iD

ACS Nano · 21.01.2025 · 19 (2) · 2742-2758

DOI: 10.1021/acsnano.4c15130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.01.2025. Verfasst von Shengting Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Small Interfering, Interleukin-11, Pulmonary Fibrosis. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Xiamen Municipality, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, Small InterferingInterleukin-11Pulmonary FibrosisBleomycinAnimalsMiceAdministration, InhalationPolyethyleneimineHumansMice, Inbred C57BLMale

Stichwörter der Autor:innen

fibrotic lesionsinhaled administrationpulmonary fibrosisrespiratory diseasessiRNA delivery system

Substanzen

BleomycinRNA, Small InterferingInterleukin-11Polyethyleneimine

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Institute of Functional Nano and Soft Materials, Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
  • College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.

ORCID-Profile: Huapan Fang, Qian Chen, Yang Yang

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Xiamen Municipality
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Program of Shanghai Academic Research Leader
  • Shanghai Municipal Key Clinical Specialty

Zitieren

APA

Dong, S., Fang, H., Zhu, J., Wu, Z., Liu, Y., Zhu, J., Ma, B., Chen, Q., & Yang, Y. (2025). Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis. ACS Nano, 19(2), 2742-2758. https://doi.org/10.1021/acsnano.4c15130

Vancouver

Dong S, Fang H, Zhu J, Wu Z, Liu Y, Zhu J, et al. Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis. ACS Nano. 2025;19(2):2742-2758. doi:10.1021/acsnano.4c15130

BibTeX
@article{Dong2025,
  author = {Dong, Shengting and Fang, Huapan and Zhu, Junjie and Wu, Zhiqiang and Liu, Yi and Zhu, Jiafei and Ma, Benting and Chen, Qian and Yang, Yang},
  title = {Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {2},
  pages = {2742--2758},
  doi = {10.1021/acsnano.4c15130}
}
Kostenlos starten →